Whether you did not know about the event (yet) or simply missed the live...fear not, you can still watch part of the content on the EFMC YouTube Channel
- 5 Rules for Effective Writing in the Sciences
Dr David Peralta (ChemMedChem, A Chemistry Europe Journal)
- Round Table discussion - "Secrets of Scientific Writing - The Unwritten Rules"
Dr Yves P. Auberson (Novartis, Switzerland)
Prof. Maria-Laura Bolognesi (University of Bologna, Italy)
Prof. Stuart Conway (University of Oxford, United Kingdom)
Dr David Peralta (ChemMedChem, A Chemistry Europe Journal)
- Integrated Drug Discovery within CRO Network
Dr Luc Van Hijfte (MercachemSyncom, The Netherlands)
- Stress Management for Mental Well-Being
Mrs Anabel Jiménez (Education First, Switzerland)
- Round Table discussion - "How to Deal with the Stressful Moments: PhD Defense, Job Interview, Team Management, etc"
Dr Dave Alker (Consultant, United Kingdom)
Dr João António (University of Lisbon, Portugal)
Mrs Anabel Jiménez (Education First, Switzerland)
Prof. Antti Poso (University of Eastern Finland, Finland)
In these very unusual times, the EFMC decided to adapt the annual "Photo Competition" to the period and run it via Instagram!
How does it work!?
Share your best #backtothelab picture and tag @euromedchem - the most liked picture at the deadline of August 31 will win the prize!
Please be careful, we might be back to the lab but the virus is still out there, so be safe and responsible!
The chemistry community still faces attitudes of discrimination that affects people’s careers and lives, and adversely affects working environments in many institutions.
EFMC actively promotes equal opportunities, honesty, fairness, transparency, and aims at an inclusive representation of all its members in its activities. It acts with the highest degree of professionalism and ethical values, stands up for the principles it promotes, and strives to have a positive influence in the scientific community. It encourages diversity of views, and participation in its initiatives and scientific events independently of gender, nationality, personal characteristics or circumstances.
EFMC is committed to promote diversity and inclusion, and invites the medicinal chemistry and chemical biology community to support our position on these issues.
In the course of the last months, EFMC launched a serie of Quizzes mixing science facts and questions about EFMC history. Many contestants competed to win one of the "EFMC Goodiebox" and we want to thank you all for your participation.
Here are the winners and runners-up:
- 1st Quiz
- Davide Benedetto Tiz (Croatia)
- Katja Veber (Slovenia)
- Pavla Perlikova (Czech Republic)
- 2nd Quiz
- Jack Roberts (United Kingdom)
- Matjaz Brvar (Germany)
- Kristina Pavic (Croatia)
- 3rd Quiz
- Adam Smalley (United Kingdom)
- Hrvoje Rimac (Hungary)
- Usman Shabbir (United Kingdom)
EFMC plans to launch similar events in the near future, so stay tuned to our website and social media!
It’s with great pleasure that we release new content on Best Practices in Medicinal Chemistry.
Copyright broadly refers to the legal rights of an owner of intellectual property, but the principles are not always clear to non-experts. Copyright is, however, present at every stage of scientific research and we face their implications daily, sometimes without knowing it.
In two slide decks, Martine Roth (Principal Trademark Attorney & Copyright at Novartis Pharma AG) briefly present the basic of copyright and introduce "Creative Commons", a nonprofit organization enabling the sharing and use of creative works through free legal tools.
Files can be found under this link.
The current pandemic has repercussions through the entire world, and of course EFMC also endures its consequences. While postponing several events, we however kept in mind that challenges create opportunities, and we are now developing an online offer to keep our community dynamic and well-connected. You will find some initial information about the next steps in this newsletter. Stay tuned to EFMC over the next few months, and take advantage of our upcoming activities and virtual symposia.
We are not at the end of the pandemic, not yet, and we learned a few good lessons already. We learned that even though good hygiene can bend an epidemic effectively, medicinal chemistry and chemical biology will remain critical in discovering these badly needed drugs and vaccines. We saw that our community is flexible in difficult times, and that academia and pharmaceutical industries can come together to make science progress very fast. I hope we will remember that after the pandemic. Looking back at how fast our knowledge of the disease has progressed, it is worth ensuring that we collaborate better in the future. We have also learned new ways to work and interact while staying at home. Will it influence our travelling, work and consumption habits, and help reduce stress and environmental impact in the long term? It is up to us. I hope we will all take the opportunity of this experience to pause, think, and implement solutions for a better future.
For now, please keep leading by example and actively spread science-based information about the pandemic. Our scientific community can contribute help and guidance through the first steps of de-confinement. It is important to show patience and do it right as we do not want to see a second wave of contamination. We also want to fight unnecessary fears, which in the long term would handicap our society. After these difficult months, let’s get ready to embrace a future that capitalizes on the new opportunities, and the best possible science.
I’m looking forward to seeing you all again soon – maybe virtually?
Stay healthy and confident,
The EFMC is happy to announce the names of the 2020 Award winners.
For his leading contributions as a pioneer of GPCR drug discovery and structural biology, and his support of the medicinal chemistry and chemical biology community. His research led to over 450 publications, many of them achieving high international visibility. An excellent mentor and lecturer, Ad IJzerman played an active role in the International LACDR School on Medicinal Chemistry. He also chaired the medicinal chemistry division of the Royal Netherlands Chemical Society, organized many scientific symposia, and led several international research networks.
Dr Malin Lemurell (AstraZeneca, Sweden)
For her contribution to the discovery and development of several drug candidates and her leadership in medicinal chemistry. Her most recent contributions while leading a 60-strong medicinal chemistry group at AstraZeneca to deliver on pipeline projects in the Cardiovascular, Renal and Metabolism disease area across multiple modalities also includes harnessing innovation in the fields of RNA targeting with small molecules, RNA imaging with fluorescent nucleotide probes, machine learning applications in drug discovery projects and new modalities.
For his pioneering work integrating machine learning into medicinal chemistry, drug discovery and chemical biology. His contributions spread across the whole drug discovery process, and introduced visionary concepts for concrete applications of computational methods. These are now broadly adopted in drug discovery and recognized as robust foundations for transformative advancements in the field.
All 3 awards consist of a diploma, € 7.500 and an invitation to give a headline presentation at the EFMC International Symposium on Medicinal Chemistry.
The 2020 Awards will be presented at the XXVI EFMC "International Symposium on Medicinal Chemistry" (EFMC-ISMC 2020) to be held in Basel, Switzerland on September 6-10, 2020.
The EFMC is happy to announce the names of the 2020 Prize winners.
The selection committee designated Prof. Yimon Aye (EPFL, Switzerland) as the winner of the 2020 EFMC Prize for a Young Medicinal Chemist in Academia. Prof. Andrea Ablasser (EPFL, Switzerland) and Dr Christoph Rademacher (MPICI, Germany) have been recognised as the most meritorious runners-up.
The selection committee designated Dr Giuseppe Cecere (F. Hoffmann-La-Roche, Switzerland) as the winner of the 2020 EFMC Prize for a Young Medicinal Chemist in Industry. Dr Julien Lefranc (Bayer, Germany) and Dr Anneli Nordqvist (AstraZeneca, Sweden) have been recognised as the most meritorious runners-up.
The two Prizes are given annually and consists of a diploma, € 1.000 and an invitation for a short presentation at an EFMC symposium.
The selection committee designated Dr Victor Sebastian Perez (CSIC, Spain) as the winner of the 2020 EFMC-YSN PhD Prize. Mrs Marta Serafini (Università del Piemonte Orientale, Italy) is the most meritorious runner-up.
The Prize will constist of a diploma, a free registration and a 500€ travel grant to attend an EFMC Symposium.
EFMC more that anything is a community, and we want to celebrate all those who contributed to its success over the past 50 years!
Whether they contributed through events, awards, prizes, committees, Council membership, workshops or just by being part of the greater EFMC family of Medicinal Chemists and Chemical Biologists. We want to thank all those who helped establish and shape the EFMC, those who pilot it nowadays and those who will take over in the future.
Now more than ever, the world need scientists that can cooperate and share their knowledge around the globe!
The below collage can only capture a small part of our members and activities, but we hope you will like it! We also call for more pictures to continue celebrating our achievements and our members.
To kick off our 50th anniversary celebrations, we would like to recognise the immense contribution of those who not only brought EFMC into being in December 1969 but have helped to make it what it is today. We are, therefore, very proud to announce the award of the first EFMC Honorary Fellows.
The first recipients have created and nurtured the mission and vision of EFMC during its first 50 years. All are former Presidents but have been contributors above and beyond and remain active supporters of EFMC. Congratulations and thanks to:
• Prof. Henk Timmerman (VU University, The Netherlands)
• Prof. Ferran Sanz (University Pompeu Fabra, Spain)
• Prof. Roberto Pellicciari (TES Pharma, Italy)
• Prof. Gerhard Ecker (University of Vienna, Austria)
• Prof. Uli Stilz (Novo Nordisk, United States)
• Prof. Koen Augustyns (University of Antwerp, Belgium)
Additionally, due to his contribution in launching the series of EFMC-YMCS events, we are happy to recognize also:
• Prof. Chris De Graaf (Sosei Heptares, United Kingdom)
The official ceremony will take place during the opening of the XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2020), scheduled to take place in Basel, Switzerland from September 6-10, 2020.
The EFMC recognition programme will continue awarding outstanding contributors to EFMC and sciences in the future with a system of open call for nominations – to be launched in fall 2020.
The official EFMC Yearbook 2020, "Medicinal Chemistry in Europe" is a valuable resource for those interested in quickly finding information on all things EFMC, such as the activities and composition of Member Societies, Corporate Members and the activities and events of EFMC and its working groups.